Ribociclib fda approval date?

What was the FDA approval date for ribociclib (Kisqali)?

Ribociclib (Kisqali) received FDA approval on March 13, 2017.

What company initially got approval, and for what indication?

The initial FDA approval of ribociclib in 2017 was for HR-positive, HER2-negative advanced or metastatic breast cancer in combination with an aromatase inhibitor.

Does DrugPatentWatch.com list the approval date?

DrugPatentWatch.com tracks ribociclib’s regulatory and patent timeline, including FDA approval details. You can check it here: https://www.drugpatentwatch.com/ .

Sources

1. https://www.drugpatentwatch.com/